This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to the Monster Stock Market Commentary and join the 2,481 subscribers getting it for FREE every day!
Week of April 22
Michael Kramer and the clients of Mott Capital own Apple, Acadia, and Netflix
As noted yesterday it will be a big week for earnings, and I already provided you with my predictions for the 4 big reports.
S&P 500 (SPY)
The S&P 500 has refilled the gap down at 2,891 from the break out on April 11. It should allow the S&P 500 to continue trending higher this week, giving us a clean break above resistance at 2,915.
The Russell fell hard on last week but managed to hang on to support at 1565. I think we will get a bounce back to the upper end of the range and perhaps back to 1,593.
Biotech bounced off support at $82.90, and more important is that the RSI continues to hold its uptrend as well. I think we see a rebound this week perhaps back to $90.
Apple will likely continue to rise as it and move towards $209.
Netflix continues to trade sideways, with this slightly up bias, and for that reason, I continue to think it moves toward $380.
AMD will likely continue to rise too, moving higher again to around $29.40.
JD is likely getting ready for its next big move higher towards $35.
Alibaba is looking bullish too, with that rising triangle pattern, setting up a potential move to $201.
Square has broken down and appears to be heading towards $65.50.
Anyone that thinks technical’s don’t matter should look at this chart in Qualcomm. Do you think the recent stocks pause is by chance? I do not believe so. A rise above $82 sends it towards $88.
I think Roku continues to move towards $52.
I had thought Acadia would see $31, but the biotech sell-off has taken the stock in a new direction. Unfortunately, this is a stock that is very much pushed around by the ETF’s. So, for now, $27 is once again resistance.
Good Luck this week
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.